Is Johnson & Johnson a Buy After Its Proposed $8.9 Billion Talc Settlement?
17/4 14:36
Healthcare giant Johnson & Johnson's (NYSE: JNJ) talcum powder litigation has hung over the company like a cloud for years. Could the storm soon pass? J&J recently announced it would settle with tens of thousands of plaintiffs in an agreement worth $8.9 billion....